CapEx at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s capex?
- Mirum Pharmaceuticals, Inc. (MIRM) reported capex of $664K in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s capex changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s capex increased by 1519.5% year-over-year, from $41K to $664K.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s capex?
- Over 3 years (2021 to 2025), Mirum Pharmaceuticals, Inc.'s capex has grown at a 241.3% compound annual growth rate (CAGR), from $24K to $954K.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.